Top Categories
Products
Add Listing
STAR-001 | Starlight Therapeutics
Product description
STAR-001 is Starlight Therapeutics’ lead drug candidate, a novel therapeutic agent being developed for the treatment of CNS cancers, including glioblastoma, brain metastases, and ATRT.
Starlight Therapeutics
Plano, United States (US)
Price:
N/A
Quote request
Message
